SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-015764
Filing Date
2021-03-16
Accepted
2021-03-16 17:28:29
Documents
66
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_hoththerapeuticsinc.htm 10-K 986235
2 DESCRIPTION OF THE REGISTRANT'S SECURITIES f10k2020ex4-5_hoththerap.htm EX-4.5 19711
3 SUBSIDIARIES OF THE REGISTRANT f10k2020ex21-1_hoththera.htm EX-21.1 2047
4 CONSENT OF WITHUMSMITH+BROWN, PC f10k2020ex23-1_hoththera.htm EX-23.1 1645
5 CERTIFICATION f10k2020ex31-1_hoththera.htm EX-31.1 11683
6 CERTIFICATION f10k2020ex31-2_hoththera.htm EX-31.2 11688
7 CERTIFICATION f10k2020ex32-1_hoththera.htm EX-32.1 5286
14 GRAPHIC img_001.jpg GRAPHIC 63299
  Complete submission text file 0001213900-21-015764.txt   4396445

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE hoth-20201231.xml EX-101.INS 531196
9 XBRL SCHEMA FILE hoth-20201231.xsd EX-101.SCH 66920
10 XBRL CALCULATION FILE hoth-20201231_cal.xml EX-101.CAL 25304
11 XBRL DEFINITION FILE hoth-20201231_def.xml EX-101.DEF 254114
12 XBRL LABEL FILE hoth-20201231_lab.xml EX-101.LAB 492600
13 XBRL PRESENTATION FILE hoth-20201231_pre.xml EX-101.PRE 268026
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38803 | Film No.: 21747180
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences